ACADIA Pharmaceuticals Inc.

ACAD Stock Healthcare Biotechnology
$30.57
+0.92 (+3.10%)
Price as of Aug 25, 2026 market close

Performance

1 Month
+20.4%
3 Months
+43.8%
YTD
+14.5%
1 Year
+18.8%

Price return, based on split- and dividend-adjusted closing prices.

Risk

Volatility 1-year annualized
38.0%
Largest decline max drawdown, since Aug 2025
-27.6%
Risk-adjusted return Sharpe ratio, 1-year
0.64

Own ACAD?

See how ACAD contributes to your portfolio's return, allocation, and risk.

7-day free trial, then $9/month.